BioAssay Systems Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BioAssay Systems's estimated annual revenue is currently $2.5M per year.(i)
  • BioAssay Systems's estimated revenue per employee is $155,000

Employee Data

  • BioAssay Systems has 16 Employees.(i)
  • BioAssay Systems grew their employee count by 7% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is BioAssay Systems?

BioAssay Systems develops and markets innovative and high-throughput assay solutions to satisfy the ever increasing demands of the life sciences industry. BioAssay Systems offers assay kits that are simple and convenient to use, which are superior in performance and require little to no time for assay optimization. We focus on safe, non-radioactive formats such as absorbance, fluorescence and luminescence detection techniques. Our list of products and applications is continually expanding and currently encompasses the following areas: Assay Kits & Reagents » Blood & Urine Chemistry » Metabolism » Enzyme Activity » Anions & Cations » Oxidative Stress » Signal Transduction » HTS Reagents » Other Reagents Equipment & Accessories » Cell Analyzers » Handheld Readers » Microplate Readers » Microtiter Plates Services » Analytical Services » Assay Customization » Assay Design & Development » Lead Discovery Services BioAssay Systems' scientists have strong expertise in assay and analytical techniques. We offer assay development and analytical services.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.6M167%$10.5M
#2
$2.5M16-11%N/A
#3
$1M17-23%N/A
#4
$2.8M17-37%N/A
#5
$2.2M186%N/A